- Home
- DOMH vs NURO Comparison
DOMH vs NURO Comparison
Compare DOMH & NURO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DOMH
- NURO
- Stock Information
- Founded
- DOMH 1967
- NURO 1996
- Country
- DOMH United States
- NURO United States
- Employees
- DOMH N/A
- NURO N/A
- Industry
- DOMH Biotechnology: Pharmaceutical Preparations
- NURO Medical/Dental Instruments
- Sector
- DOMH Health Care
- NURO Health Care
- Exchange
- DOMH Nasdaq
- NURO Nasdaq
- Market Cap
- DOMH 8.8M
- NURO 8.2M
- IPO Year
- DOMH N/A
- NURO N/A
- Fundamental
- Price
- DOMH $4.59
- NURO $4.37
- Analyst Decision
- DOMH
- NURO
- Analyst Count
- DOMH 0
- NURO 0
- Target Price
- DOMH N/A
- NURO N/A
- AVG Volume (30 Days)
- DOMH 427.5K
- NURO 21.7K
- Earning Date
- DOMH 03-31-2025
- NURO 02-20-2025
- Dividend Yield
- DOMH N/A
- NURO N/A
- EPS Growth
- DOMH N/A
- NURO N/A
- EPS
- DOMH N/A
- NURO N/A
- Revenue
- DOMH $12,589,000.00
- NURO $3,767,764.00
- Revenue This Year
- DOMH N/A
- NURO N/A
- Revenue Next Year
- DOMH N/A
- NURO N/A
- P/E Ratio
- DOMH N/A
- NURO N/A
- Revenue Growth
- DOMH 1117.50
- NURO N/A
- 52 Week Low
- DOMH $0.83
- NURO $2.66
- 52 Week High
- DOMH $5.92
- NURO $4.73
- Technical
- Relative Strength Index (RSI)
- DOMH 79.30
- NURO 67.97
- Support Level
- DOMH $2.55
- NURO $4.16
- Resistance Level
- DOMH $4.35
- NURO $4.40
- Average True Range (ATR)
- DOMH 0.62
- NURO 0.09
- MACD
- DOMH 0.17
- NURO 0.03
- Stochastic Oscillator
- DOMH 82.13
- NURO 95.24
About DOMH Dominari Holdings Inc.
Dominari Holdings Inc is a biotechnology company with a diverse portfolio of small-molecule anticancer and antiviral therapeutics in development. The company's oncology therapeutics include treatments for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia.
About NURO NeuroMetrix Inc.
NeuroMetrix Inc is a commercial-stage healthcare company. Its core business activities are integrated with in-house capabilities spanning product development, manufacturing, regulatory affairs and compliance, sales and marketing, and customer support. The company produces bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The product line of the company includes Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. The company operates in a single segment being Medical equipment and consumables.